U.P. Strauss

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Bonne Biesma, David F. Heigener et al. · Journal of Clinical Oncology · 2012 · 256 citations · Full text

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings

Jochaim Beck, Giuseppe Procopio, Emilio Bajetta et al. · Annals of Oncology · 2011 · 135 citations

Urology, Genitourinary Cancer, Medicine +8

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

Tim Eisen, Richard Marais, Annette Affolter et al. · British Journal of Cancer · 2011 · 43 citations · Full text

Efficacy and safety of intrapatient dose escalation of sorafenib as first-line treatment for metastatic renal cell carcinoma (mRCC).

M. Gore, R. J. Jones, Alain Ravaud et al. · Journal of Clinical Oncology · 2011 · 24 citations

Cancer Management, First-line Treatment, Pharmacotherapy +18

Nail Penetration of Sertaconazole with a Sertaconazole-Containing Nail Patch Formulation

Rudy Susilo, Hans Christian Körting, Wolfgang Greb et al. · American Journal of Clinical Dermatology · 2006 · 22 citations

Nail Penetration, Dermatology